Leili Rahimi

Leili Rahimi

Mayo Clinic - Rochester / United States
Medical and Health Sciences / Endocrinology and Metabolism
AD Scientific Index ID: 4851633
Mayo Clinic College of Medicine and Science
person_outline Leili Rahimi's MOST POPULAR ARTICLES
1-) Factors Leading to High Morbidity and Mortality of COVID‐19 in Patients with Type 2 DiabetesA Rajpal, L Rahimi, F Ismail‐BeigiJournal of Diabetes, 20201342020
2-) Glucocorticoid-Induced Fatty Liver DiseaseL Rahimi, A Rajpal, F Ismail-BeigiDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 13, 1133-1145, 2020472020
3-) Disturbances in insulin–glucose metabolism in patients with advanced renal disease with and without diabetesMN Rahhal, NE Gharaibeh, L Rahimi, F Ismail-BeigiThe Journal of Clinical Endocrinology & Metabolism 104 (11), 4949-4966, 2019272019
4-) SGLT-2 inhibitors as promising therapeutics for non-alcoholic fatty liver disease: pathophysiology, clinical outcomes, and future directionsNE Gharaibeh, MN Rahhal, L Rahimi, F Ismail-BeigiDiabetes, metabolic syndrome and obesity: targets and therapy 12, 1001-1012, 2019362019
5-) Evolution of insulin at the edge of foldability and its medical implicationsNK Rege, M Liu, Y Yang, B Dhayalan, NP Wickramasinghe, YS Chen, ...Proceedings of the National Academy of Sciences 117 (47), 29618-29628, 2020332020